
Abstract Background: Snakebite envenomation caused by G. brevicaudus and D. acutus frequently presents with overlapping hemorrhagic and coagulopathic manifestations in clinical settings. However, whether these similarities reflect convergent venom phenotypes remains unclear. Methods: We performed an integrated comparative analysis combining nano-LC-MS/MS proteomics with multi-target functional assays to systematically evaluate venom composition and biological activities. Proteomic profiling was used to characterize toxin family abundance, while enzymatic, cytotoxic, hemolytic, and cell signaling assays were conducted to assess functional effects. Results: Proteomic analysis revealed that both venoms are predominantly composed of hemotoxic toxin families, including snake venom metalloproteinases (SVMP), snake venom serine proteases (SVSP), C-type lectin-like proteins (CTLP), and phospholipase A₂ (PLA₂), with broadly comparable relative abundances. Functional assays demonstrated similar concentration-dependent patterns in proteolytic, PLA₂, thrombin-like, and fibrinolytic activities, with no statistically significant interspecific differences. Both venoms also induced comparable cytotoxic effects across mammalian cell lines, while exhibiting limited hemolytic activity and minimal modulation of Ca²⁺ signaling and nitric oxide production. Conclusions: These findings demonstrate that G. brevicaudus and D. acutus venoms share a convergent hemotoxic functional architecture characterized by consistent enzymatic activities and similar cytotoxic profiles. This functional convergence provides a mechanistic basis for clinically overlapping hemorrhagic and coagulopathic manifestations observed in envenomation cases. The results further emphasize the importance of function-oriented venom profiling and suggest potential implications for antivenom cross-reactivity and therapeutic development.
ABSTRACT Background: The increasing incidence of Candida glabrata complex infections in hospitalized patients and their association with high mortality rates prompted the determination of cryptic species among clinical isolates from a tertiary hospital and the evaluation of their susceptibility profiles to commonly prescribed antifungal agents. Methods: This study evaluated 80 C. glabrata isolates obtained from patients admitted to a Brazilian public tertiary hospital. The isolates were recovered from different clinical specimens, predominantly urine and blood, across various medical units. Results: MALDI-TOF MS analysis revealed that all isolates were Candida glabrata sensu stricto. Minimum inhibitory concentrations (MICs), determined via broth microdilution and according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines, showed high susceptibility to amphotericin B (AmB), voriconazole (VRC), and echinocandins (ECNs) [caspofungin (CSF), anidulafungin (ANF), and micafungin (MCF)], as well as uniform susceptibility within the "I" category (susceptible, increased exposure) to fluconazole (FLC). Comparisons of resistance profiles revealed higher prevalences of resistance to AmB and VRC than to ECNs, both overall and in urine isolates, with a similar trend observed in blood isolates. Comparative analysis with reference EUCAST C. glabrata data highlighted higher localized MIC values for AmB, ANF, and MCF, lower MICs for FLC, and equivalent distributions for VRC. Conclusion: All recovered isolates were confirmed as Candida glabrata sensu stricto and exhibited different susceptibility profiles from reference EUCAST isolates. These findings establish a strong regional baseline, serving as a useful guide for monitoring therapeutic measures and supporting antimicrobial stewardship.
Abstract Background: Although bone tissue possesses inherent regenerative capacity, critical-sized defects require grafts for complete functional repair. This in vivo study evaluated the bone repair process using laser photobiomodulation therapy (PBM) in defects filled with a combination of hydroxyapatite, β-tricalcium phosphate and heterologous fibrin biopolymer (HFB). Methods: Thirty male rats were divided into three groups: biomaterial alone (BG), biomaterial + HFB (BBG), and biomaterial + HFB + PBM (BBPG). A 5-mm circular calvarial osteotomy was performed and filled according to each protocol. In BBPG, an 830-nm laser was applied immediately post-surgery and three times weekly until euthanasia at 14 or 42 days. Analyses included micro-CT, histomorphology, histomorphometry, and polarized light microscopy of collagen fibers. Results: Micro-CT showed centripetal bone regeneration restricted to defect margins, with biomaterial particles persisting centrally. Histologically, new bone progressed from immature trabecular architecture at day 14 to a mature lamellar conformation by day 42, notably in BBPG. All groups showed a significant temporal increase in new bone percentage. BBPG demonstrated superior bone growth at 42 days (26.64 ± 2.15%) compared to BG (14.85 ± 1.63%) and BBG (20.05 ± 1.70%). The birefringence of the collagen fibers showed a color transition from red to yellowish-green during the analyzed periods. Conclusion: The combination of the biomaterial, fibrin biopolymer and photobiomodulation significantly enhanced bone defect repair and matrix maturation without barrier membranes, presenting high translational potential for cost-effective clinical applications in regenerative medicine.
Background:In the Brazilian Amazon, most snakebites are caused by Bothrops atrox. Although pediatric cases are less frequent, children are more vulnerable to severe complications and long-term disabilities. This study aims to describe the clinical profile of B. atrox envenomation in children treated at a tertiary hospital in Manaus, in Western Brazilian Amazon, and to characterize the resulting long-term musculoskeletal impairments in a subgroup of these patients. Methods:We retrospectively analyzed sociodemographic and clinical data from patients up to 12 years and 11 months of age treated between January 2010 and December 2023. A total of 258 children who were victims of B. atrox envenoming were eligible; however, a subgroup of 27 children underwent in-person musculoskeletal evaluations starting three months after hospital discharge. Results:In the subgroup of children evaluated, the majority were male (63%), were aged over ten years (59.3%), and were from rural areas (96.3%). Over half (51.8%) received medical care within six hours after the bite. The lower limbs were most frequently affected (96.3%). Common local symptoms included pain (100%), edema (96.3%), bleeding (37%), and bruising (29.6%). Secondary infections occurred in 18.5% of cases. Most envenomations were classified as moderate in severity (44.4%). In this subgroup, long-term disabilities were identified in 21 children (77.7%), who presented primarily with intermittent chronic pain (55.5%). Physical examination revealed scars (59.3%), edema (22.2%), and deformities (3.7%). Sensory alterations were noted in tactile (11.1%), pain (25.9%), thermal (22.2%), and vibratory (29.6%) sensitivity. Range of motion was impaired in 37% of cases, and one child exhibited abnormal posture and reflexes. Conclusions:This study highlights a broad spectrum of persistent musculoskeletal sequelae following Bothrops envenomation in children. Our findings underscore the urgent need for comprehensive care, follow-up, and rehabilitation programs for pediatric snakebite victims in the Amazon region.
Background:Envenomation by Daboia siamensis venom (RVV) can cause acute kidney injury (AKI), but its mechanisms remain unclear. Renal cell death via necrosis and apoptosis is central to AKI progression. Bax and Bcl-2 are key pro- and anti-apoptotic regulators and common markers of apoptosis; however, their roles in RVV-induced renal injury are poorly defined. Therefore, we investigated Bax and Bcl-2 gene expression and their ratio in AKI following the administration of RVV and its venom fractions. Methods:Kidney tissue samples from intact rabbits (in vivo) and the isolated perfused kidney (IPK) model treated with RVV and its venom fractions (PLA₂, MP, LAAO, and PDE) were analyzed for Bcl-2 family expression at both mRNA and protein levels, together with histopathological evaluation. Bcl-2 and Bax mRNA expression was quantified by RT-qPCR using the ΔΔCt method, and protein expression was assessed by immunohistochemical analysis. Results:Following the administration of RVV and its venom fractions, histopathological analysis revealed extensive tubulonephrosis across all renal tubular segments in both intact kidneys and the IPK model. In contrast, renal tubular necrosis involving all tubular segments occurred in the IPK model after exposure to the RVV, PLA₂ and MP fractions. Immunohistochemical analysis revealed a trend toward increased Bax protein expression and decreased Bcl-2 expression in multiple tubular segments compared to controls in both models. RT-qPCR analysis demonstrated a 1.5-fold upregulation of Bcl-2 and significant reductions in Bax expression and the Bax/Bcl-2 ratio (p < 0.05) in the IPK model relative to controls. Conclusions:Envenomation with RVV and its venom fractions induced nephrotoxic acute kidney injury by modulating Bax- and Bcl-2-mediated apoptosis in renal tubular epithelial cells, with greater susceptibility observed in intact kidneys and a reduced apoptotic response in the IPK model. These findings suggest that prolonged venom exposure may be partially reversible or may shift cell-death signaling from apoptosis toward necrosis.